AA

Arumugam Anandammal

Active Director Director DIN 08082779
DIN 08082779 First appointment Mar 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Arumugam Anandammal

Data last updated:

Arumugam Anandammal is a Director at Qmed Hospital Private Limited (since 2018). The company operates in Healthcare. Qmed Hospital Private Limited reported revenue of ₹3.06 Cr (FY 2025).

DIN 08082779
Primary Designation Director
Industry Healthcare
First Appointment 10 Mar 2018
Oldest Company Age 9 yrs
Largest company Qmed Hospital Private Limited · ₹3.06 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Qmed Hospital Private Limited U85200TN2017PTC114921
Director10 Mar 20182017₹3.06 Cr (FY 2025)Active

Board colleagues of Arumugam Anandammal

Directorship timeline

Open interactive timeline →
Qmed Hospital Private Limited
Premium access

Shareholding and investment profile for Arumugam Anandammal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arumugam Anandammal

Arumugam Anandammal currently holds 1 directorship: Qmed Hospital Private Limited (Director, since 10 Mar 2018, revenue ₹3.06 Cr (FY 2025)).

Arumugam Anandammal was first appointed on 10 Mar 2018 as Director at Qmed Hospital Private Limited.

The current boards of Arumugam Anandammal's companies include Karuppaiah Jaya Prakash Narayanan (Qmed Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available